Enhancing pre-clinical research with simplified intestinal cell line models

被引:2
作者
Fey, Christina [1 ]
Truschel, Theresa [2 ]
Nehlsen, Kristina [2 ]
Damigos, Spyridon [3 ]
Horstmann, Julia [4 ]
Stradal, Theresia [4 ]
May, Tobias [2 ]
Metzger, Marco [1 ,3 ]
Zdzieblo, Daniela [1 ,3 ,5 ]
机构
[1] Branch Fraunhofer Inst Silicate Res ISC, Translat Ctr Regenerat Therapies TLZ RT Wurzburg, Rontgenring 12, D-97070 Wurzburg, Germany
[2] InSCREENeX GmbH, Braunschweig, Germany
[3] Univ Hosp Wurzburg, Dept Tissue Engn & Regenerat Med TERM, Wurzburg, Germany
[4] Helmholtz Ctr Infect Res, Braunschweig, Germany
[5] Branch Fraunhofer Inst Silicate Res ISC, Project Ctr Stem Cell Proc Engn PZ SPT, Wurzburg, Germany
关键词
Small intestinal tissue; immortalization; organoids; cell line; Transwell (R) models; SOLUTE CARRIER TRANSPORTERS; IN-VITRO MODEL; EPITHELIAL-CELLS; CULTURE-SYSTEM; DRUG TRANSPORT; STEM-CELLS; IMMORTALIZATION; PERMEABILITY; TELOMERASE; MUCUS;
D O I
10.1177/20417314241228949
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Two-dimensional culture remains widely employed to determine the bioavailability of orally delivered drugs. To gain more knowledge about drug uptake mechanisms and risk assessment for the patient after oral drug admission, intestinal in vitro models demonstrating a closer similarity to the in vivo situation are needed. In particular, Caco-2 cell-based Transwell (R) models show advantages as they are reproducible, cost-efficient, and standardized. However, cellular complexity is impaired and cell function is strongly modified as important transporters in the apical membrane are missing. To overcome these limitations, primary organoid-based human small intestinal tissue models were developed recently but the application of these cultures in pre-clinical research still represents an enormous challenge, as culture setup is complex as well as time- and cost-intensive. To overcome these hurdles, we demonstrate the establishment of primary organoid-derived intestinal cell lines by immortalization. Besides exhibiting cellular diversity of the organoid, these immortalized cell lines enable a standardized and more cost-efficient culture. Further, our cell line-based Transwell (R)-like models display an organ-specific epithelial barrier integrity, ultrastructural features and representative transport functions. Altogether, our novel model systems are cost-efficient with close similarity to the in vivo situation, therefore favoring their use in bioavailability studies in the context of pre-clinical screenings.
引用
收藏
页数:20
相关论文
共 67 条
[1]   Changes in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axes [J].
Anderle, P ;
Sengstag, T ;
Mutch, DM ;
Rumbo, M ;
Praz, V ;
Mansourian, R ;
Delorenzi, M ;
Williamson, G ;
Roberts, MA .
BMC GENOMICS, 2005, 6 (1)
[2]  
[Anonymous], 2018, Explor Res Hypothesis Med
[3]  
[Anonymous], 2004, Statistical Applications in Genetics and Molecular Biology, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]
[4]   Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996) [J].
Artursson, P ;
Palm, K ;
Luthman, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :27-43
[5]  
Artursson P., 2007, Comprehensive Medicinal Chemistry II, P259, DOI DOI 10.1016/B0-08-045044-X/00126-7
[6]   Cell culture-based models for intestinal permeability: a critique [J].
Balimane, PV ;
Chong, S .
DRUG DISCOVERY TODAY, 2005, 10 (05) :335-343
[7]   Regulation and plasticity of intestinal stem cells during homeostasis and regeneration [J].
Beumer, Joep ;
Clevers, Hans .
DEVELOPMENT, 2016, 143 (20) :3639-3649
[8]   ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks [J].
Bindea, Gabriela ;
Mlecnik, Bernhard ;
Hackl, Hubert ;
Charoentong, Pornpimol ;
Tosolini, Marie ;
Kirilovsky, Amos ;
Fridman, Wolf-Herman ;
Pages, Franck ;
Trajanoski, Zlatko ;
Galon, Jerome .
BIOINFORMATICS, 2009, 25 (08) :1091-1093
[9]   A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT [J].
Cerone, MA ;
Autexier, C ;
Londoño-Vallejo, JA ;
Bacchetti, S .
ONCOGENE, 2005, 24 (53) :7893-7901
[10]  
Chatterjee T, 2010, Med J Armed Forces India, V66, P56, DOI 10.1016/S0377-1237(10)80095-4